EW Stock Summary and Trading Ideas (Edwards Lifesciences | NYSE:EW)

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

Edwards Lifesciences trades on the NYSE stock market under the symbol EW.

As of November 4, 2026, EW stock price climbed to $96.99 with 1,449,978 million shares trading.

EW has a beta of 0.55, meaning it tends to be less sensitive to market movements. EW has a correlation of 0.07 to the broad based SPY ETF.

EW has a market cap of $55.91 billion. This is considered a Large Cap stock.

Last quarter Edwards Lifesciences reported $2 billion in Revenue and $.78 earnings per share. This beat revenue expectation by $41 million and exceeded earnings estimates by $.04.

In the last 3 years, EW traded as high as $99.79 and as low as $58.93.

The top ETF exchange traded funds that EW belongs to (by Net Assets): VTI, VOO, VO, IVV, SPY.

EW has outperformed the market in the last year with a price return of +16.8% while the SPY ETF gained +13.4%. EW has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +9.2% and +9.9%, respectively, while the SPY returned +1.5% and -0.2%, respectively.

EW support price is $93.54 and resistance is $96.84 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that EW shares will trade within this expected range on the day.